|
UBN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.91900000000268E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.83670000000391E-05 |
| Normal-vs-Stage2 |
2.604000E-02 |
| Normal-vs-Stage3 |
3.094500E-02 |
| Normal-vs-Stage4 |
1.618640E-01 |
| Stage1-vs-Stage2 |
8.665000E-01 |
| Stage1-vs-Stage3 |
2.011600E-01 |
| Stage1-vs-Stage4 |
4.886200E-02 |
| Stage2-vs-Stage3 |
4.730000E-01 |
| Stage2-vs-Stage4 |
2.496800E-01 |
| Stage3-vs-Stage4 |
5.448600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.015830E-04 |
| Normal-vs-AfricanAmerican |
4.569600E-01 |
| Normal-vs-Asian |
8.244600E-03 |
| Caucasian-vs-AfricanAmerican |
4.359600E-02 |
| Caucasian-vs-Asian |
8.515800E-03 |
| AfricanAmerican-vs-Asian |
1.640380E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.082820E-03 |
| Normal-vs-Female |
1.846360E-04 |
| Male-vs-Female |
3.151200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.170170E-01 |
| Normal-vs-Age(41-60Yrs) |
1.71879999999458E-05 |
| Normal-vs-Age(61-80Yrs) |
9.856200E-03 |
| Normal-vs-Age(81-100Yrs) |
7.722000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.090800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.896800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.482600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.050200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.255960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.230800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.104000E-02 |
| Normal-vs-Grade 2 |
1.08539999998936E-06 |
| Normal-vs-Grade 3 |
1.020240E-02 |
| Normal-vs-Grade 4 |
7.966000E-01 |
| Grade 1-vs-Grade 2 |
4.351200E-01 |
| Grade 1-vs-Grade 3 |
4.474000E-02 |
| Grade 1-vs-Grade 4 |
1.803480E-03 |
| Grade 2-vs-Grade 3 |
1.015550E-02 |
| Grade 2-vs-Grade 4 |
1.84658999999865E-05 |
| Grade 3-vs-Grade 4 |
2.381600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.02039999952497E-07 |
| Normal-vs-ccB subtype |
2.789600E-02 |
| ccA subtype-vs-ccB subtype |
3.443800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.012070E-04 |
| Normal-vs-N1 |
9.333800E-01 |
| N0-vs-N1 |
1.853590E-01 |
|
|
